Barclays

Barclays’s Agile Therapeutics AGRX Stock Holding History

Barclays’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6	Closed	-$11K	–	4889
2021 Q3	$11K	Buy	6 +2	+50%	+$4.53K	﹤0.01%	4509
2021 Q2	$10K	Sell	4 -24	-86%	-$79.1K	﹤0.01%	4660
2021 Q1	$118K	Buy	28 +17	+155%	+$91.9K	﹤0.01%	3936
2020 Q4	$63K	Buy	+11	New	+$64.7K	﹤0.01%	4320
2018 Q2	–	Sell	-12	Closed	-$64K	–	7422
2018 Q1	$64K	Sell	12 -31	-72%	-$205K	﹤0.01%	5705
2017 Q4	$233K	Buy	43 +33	+330%	+$307K	﹤0.01%	4567
2017 Q3	$93K	Sell	10 -4	-29%	-$30.7K	﹤0.01%	4982
2017 Q2	$107K	Buy	14 +5	+56%	+$34.6K	﹤0.01%	4851
2017 Q1	$57K	Buy	+9	New	+$45.2K	﹤0.01%	5267
2016 Q4	–	Hold	0	–	–	–	6286
2016 Q3	–	Sell	-2	Closed	-$28.5K	–	6483
2016 Q2	$26K	Buy	+2	New	+$27.4K	﹤0.01%	5169
2015 Q4	–	Hold	0	–	–	–	6770
2015 Q3	–	Hold	0	–	–	–	7162
2015 Q2	–	Hold	0	–	–	–	6843

Other funds holding AGRX

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return